This presentation addresses the mechanism of action of chlorhexidine gluconate (CHG), defines the uses of CHG to prevent central line associated bloodstream infections (CLABSIs) in the context of extraluminal and intraluminal modes of bacterial pathogenesis and highlights the current CDC recommendations for the use of CHG to prevent CLABSI.
Wiping Away the Competition
Sign up for PDI News
Receive product announcements, educational tools, resources, and more!
PDI, makers of Sani-Cloth®, the #1 brand of disinfectant wipes in healthcare